Abstract

The therapeutic efficacy of an early treatment protocol with an infection-stage adjusted fluoroquinolone regimen was evaluated in a field study on young bulls (YBs) presenting signs of bovine respiratory disease (BRD). A total of 195 YB (Charolais, Limousin, and Rouge-des-Prés breeds) from 6 farms implementing or not prophylactic antimicrobial treatments (PROPHY or absence) were randomly assigned to 1 of 2 experiment groups based on time of detection of BRD and first-line marbofloxacin regimen, early adjusted dose [Early 2 (E2)] or late standard dose [Late 10 (L10)]. Each YB was administered orally a reticulo-rumen bolus, allowing continuous monitoring of ruminal temperature. In the E2 group, YB presenting early signs of BRD, i.e., an increase in ruminal temperature over 40.2°C and persisting more than 12 h, confirmed by a clinical examination showing no or mild signs of BRD, were given 2 mg/kg of marbofloxacin. In the L10 group, YBs presenting moderate or severe signs of BRD at visual inspection, confirmed at clinical examination, were given 10 mg/kg of marbofloxacin. If needed, YBs were given a relapse treatment. The YBs were followed for 30 days. The proportions of first and relapse treatments were calculated, as well as the therapeutic efficacy at day 10. In the E2 group, the first-line treatments’ proportion was significantly higher (P < 0.05), while the relapse treatments’ proportion tended to be higher (P = 0.08), than in the L10 group. Evolution of clinical scores (CSs) of diseased YB was followed for 10 days. In both groups, CS and rectal temperature decreased significantly 24 h after treatment (P < 0.05). Treatment incidences (TI) representing antimicrobial consumption assessed on used daily doses (UDD) were calculated. Antimicrobial consumption of marbofloxacin and relapse treatments were not significantly different between the groups. These values were strongly influenced by the recourse to a prophylactic antimicrobial treatment, accounting for more than 90% of the antimicrobial amount in the herds implementing prophylaxis. The higher number of treatments in the groups treated on the basis of ruminal temperature monitoring, the accuracy of the detection method, and the necessary conditions to implement precision antimicrobial therapy in the field are discussed in this article.

Highlights

  • Antimicrobial use (AMU) in veterinary medicine may lead to the selection of resistant bacteria, potentially transferred to humans, representing a public health hazard [1, 2]

  • Our study aimed to assess the effectiveness of a protocol using an infection-stage adjusted antimicrobial regimen administered at an early stage of bovine respiratory disease (BRD), before the onset of clinical signs observed by farmers

  • We hypothesized that such regimen could be sufficient to achieve the cure of young bulls (YBs) presenting an increase of ruminal temperature, as a proxy for onset of BRD

Read more

Summary

Introduction

Antimicrobial use (AMU) in veterinary medicine may lead to the selection of resistant bacteria, potentially transferred to humans, representing a public health hazard [1, 2]. Current practices of treatment of BRD consist of (i) treating the entire cohort of animals before the onset of BRD (prophylactic treatment) and (ii) treating the entire cohort of animals in which only a small number of animals expresses clinical signs (metaphylactic treatment or control) [8] The advantages of these mass medication strategies are the control of the infection dissemination and a good survival rate with regards to the group, promoting the prevention and/or delay of BRD in the group. This approach limits the number of animals exposed to antimicrobials It is usually seen as the “late approach,” and delay in treatment initiation may impact animal welfare, as the clinical signs possibly reflect extensive pulmonary damage which had time to develop prior to treatment [6]. These conditions lead to routine use of a “high” antimicrobial dose

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call